Sencer SF, Haake RJ, Weisdorf DJ. Hemorrhagic cystitis after bone marrow transplantation. Risk factors and complications[J]. Transplantation, 1993, 56(4): 875-879.
[2]
Bedi A, Miller CB, Hanson JL, et al. Association of BK virus with failure of prophylaxis against hemorrhagic cystitis following bone marrow transplantation[J]. J Clin Oncol, 1995, 13(5): 1103-1109.
[3]
Russell SJ, Vowels MR, Vale T. Haemorrhagic cystitis in paediatric bone marrow transplant patients: an association with infective agents, GVHD and prior cyclophosphamide[J]. Bone Marrow Transplant, 1994, 13(5): 533-539.
[4]
Arthur RR, Shah KV, Baust SJ, et al. Association of BK viruria with hemorrhagic cystitis in recipients of bone marrow transplants[J]. N Engl J Med, 1986, 315(4): 230-234.
[5]
Azzi A, Cesaro S, Laszlo D, et al. Human polyomavirus BK(BKV)load and haemorrhagic cystitis in bone marrow transplantation patients[J]. J Clin Virol, 1999, 14(2): 79-86.
[6]
Held TK, Biel SS, Nitsche A, et al. Treatment of BK virus-associated hemorrhagic cystitis and simultaneous CMV reactivation with cidofovir[J]. Bone Marrow Transplant, 2000, 26(3): 347-350.
Leung AY, Yuen KY, Kwong YL. Polyoma BK virus and haemorrhagic cystitis in haematopoietic stem cell transplantation: a changing paradigm[J]. Bone Marrow Transplant, 2005, 36(11): 929-937.
[9]
Leung AY, Suen CK, Lie AK, et al. Quantification of polyoma BK viruria in hemorrhagic cystitis complicating bone marrow transplantation[J]. Blood, 2001, 98(6): 1971-1978.
[10]
Xu LP, Zhang HY, Huang XJ, et al. Hemorrhagic cystitis following hematopoietic stem cell transplantation: incidence, risk factors and association with CMV reactivation and graft-versus-host disease[J]. Chin Med J(Engl), 2007, 120(19): 1666-1671.
[11]
Apperley JF, Rice SJ, Bishop JA, et al. Late-onset hemorrhagic cystitis associated with urinary excretion of polyomaviruses after bone marrow transplantation[J]. Transplantation,1987, 43(1): 108-112.
[12]
Przepiorka D, Weisdorf D, Martin P, et al. 1994 Consensus Conference on Acute GVHD Grading[J]. Bone Marrow Transplant, 1995, 15(6): 825-828.
[13]
Tsuboi K, Kishi K, Ohmachi K, et al. Multivariate analysis of risk factors for hemorrhagic cystitis after hematopoietic stem cell transplantation[J]. Bone Marrow Transplant, 2003, 32(9): 903-907.
[14]
Cesaro S, Brugiolo A, Faraci M, et al. Incidence and treatment of hemorrhagic cystitis in children given hematopoietic stem cell transplantation: a survey from the Italian association of pediatric hematology oncology-bone marrow transplantation group[J]. Bone Marrow Transplant, 2003, 32(9): 925-931.
[15]
Seber A, Shu XO, Defor T, et al. Risk factors for severe hemorrhagic cystitis following BMT[J]. Bone Marrow Transplant, 1999, 23(1): 35-40.
[16]
Giraud G, Bogdanovic G, Priftakis P, et al. The incidence of hemorrhagic cystitis and BK-viruria in allogeneic hematopoietic stem cell recipients according to intensity of the conditioning regimen[J]. Haematologica, 2006, 91(3): 401-404.
[17]
Giraud G, Priftakis P, Bogdanovic G, et al. BK-viruria and haemorrhagic cystitis are more frequent in allogeneic haematopoietic stem cell transplant patients receiving full conditioning and unrelated-HLA-mismatched grafts[J]. Bone Marrow Transplant, 2008, 41(8): 737-742.
[18]
El-Zimaity M, Saliba R, Chan K, et al. Hemorrhagic cystitis after allogeneic hematopoietic stem cell transplantation: donor type matters[J]. Blood, 2004, 103(12): 4674-4680.
Hirsch HH. BK virus: opportunity makes a pathogen[J]. Clin Infect Dis, 2005, 41(3): 354-360.
[21]
Silva Lde P, Patah PA, Saliba RM, et al. Hemorrhagic cystitis after allogeneic hematopoietic stem cell transplants is the complex result of BK virus infection, preparative regimen intensity and donor type[J]. Haematologica, 95(7): 1183-1190.
